KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Cash from Investing Activities (2016 - 2026)

Boston Scientific's Cash from Investing Activities history spans 18 years, with the latest figure at -$591.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 18.2% to -$591.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$2.7 billion, a 53.73% increase, with the full-year FY2025 number at -$2.6 billion, up 53.58% from a year prior.
  • Cash from Investing Activities hit -$591.0 million in Q1 2026 for Boston Scientific, down from -$512.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BSX hit a ceiling of -$29.0 million in Q2 2022 and a floor of -$3.7 billion in Q4 2024.
  • Historically, Cash from Investing Activities has averaged -$794.3 million across 5 years, with a median of -$502.0 million in 2025.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 2796.55% in 2023 and later skyrocketed 86.18% in 2025.
  • Tracing BSX's Cash from Investing Activities over 5 years: stood at -$183.0 million in 2022, then plummeted by 475.41% to -$1.1 billion in 2023, then plummeted by 251.76% to -$3.7 billion in 2024, then skyrocketed by 86.18% to -$512.0 million in 2025, then fell by 15.43% to -$591.0 million in 2026.
  • Business Quant data shows Cash from Investing Activities for BSX at -$591.0 million in Q1 2026, -$512.0 million in Q4 2025, and -$502.0 million in Q3 2025.